This post is off topic but my be helpful to those wanting

New Post Public Reply Private Reply Replies (0) Message Board
AlanC AlanC #13267
This post is off topic but my be helpful to those wanting to learn more about naked shorting. Go NTEK!!!

Third Circuit Sends 'Naked' Short Sale Case to State Court


By Charles Toutant Published: Nov 11, 2014


The U.S. Court of Appeals for the Third Circuit has remanded to New Jersey state court a suit claiming Merrill Lynch, UBS Securities, E Trade Capital Markets and other financial institutions conspired to conduct abusive “naked” short sales of the stock of Escala Group Inc.

The appeals court found no federal jurisdiction over the plaintiffs’ state-law claims, which allege that the defendants manipulated the stock price. Although the short sales at issue in the case are subject to federal scrutiny under Regulation SHO, which has no analogous provision under New Jersey law, the question of whether the defendants’ acts violate New Jersey law need not be answered by reference to Regulation SHO, the appeals court said.

A group of individuals and business entities filed the suit in Morris County Superior Court, and Merrill Lynch removed it to federal court in Newark on federal question jurisdiction. When the plaintiffs moved to remand the case to state court, U.S. Magistrate Judge Michael Hammer recommended the motion be granted in December 2012. But U.S. District Judge Jose Linares overruled Hammer in March 2013 and denied the plaintiffs’ motion to remand.

On Nov. 10, Third Circuit Judges D. Brooks Smith, Thomas Vanaskie and Dolores Sloviter reversed Linares’ ruling and instructed that the case be remanded to the Superior Court of New Jersey.

The ruling is precedential because it marks the first time any federal appeals court has ruled on the interplay between state causes of action and federal claims rising out of a racketeering suit, according to Neil Flaster, the Florham Park, N.J., solo representing the plaintiffs.

The suit was brought by Greg Manning of Boonton, N.J., and Claes Arnrup of Sweden, as well as four holding companies. All held stock in Escala Group at the time of the alleged naked short selling in 2006 and 2007. Escala Group changed its name to Spectrum Group International in 2009. Located in Irvine, Calif., the company is a dealer and auctioneer of stamps, coins, military memorabilia and other collectibles.

Besides Merrill Lynch, UBS and E Trade, the suit names Knight Capital Americas, National Financial Services and Citadel Derivatives Group as defendants. The suit claims the defendants falsified documentation of trades and loans of Escala shares while conducting transactions on their own behalf and for others.

The suit claims the defendants’ actions caused an artificial increase in the number of shares in Escala by “manufacturing fictitious and unauthorized phantom shares,” which caused the value of the plaintiffs’ holdings to decline and diluted their voting rights. The suit brought claims under the New Jersey Racketeer Influenced and Corrupt Organizations Act based on predicate acts of New Jersey securities fraud and theft, and common-law claims for unjust enrichment, interference with economic advantage and contractual relations, breach of contract, breach of the covenant of good faith and fair dealing, and negligence.

The suit says that when the naked short sales began in March 2006, the price of Escala stock fell from $32 to $4 in the course of five days.

Smith wrote for the appeals court that in a typical short sale, the seller identifies a stock that is expected to drop in price; arranges to borrow shares of the stock from a broker; sells the borrowed securities; waits for the stock to decrease in value; purchases replacement securities; and returns them to the broker.

Typically, Smith wrote, a short sale is completed within three days, but in a “naked” short sale, the buyer fails to deliver securities to the buyer within the standard three-day settlement period, as part of a scheme to manipulate the price of a stock.

Naked short selling is not per se illegal under federal law, but some naked short selling schemes may violate federal antitrust laws, as well as Regulation SHO, he said.

The defendants argued that federal jurisdiction was conferred by 28 U.S.C. 1331 and by Section 27 of the Exchange Act. In support of their Sec. 1331 claim, the defendants cited D’Alessio v. New York Stock Exchange. In that 2001 case, the Second Circuit found federal jurisdiction under Sec. 1331 where a court was required to construe federal securities laws because the plaintiff claimed the New York Stock Exchange failed to perform its statutory duty, created under federal law, to enforce members’ compliance with those laws. But the present case “is distinguishable because plaintiffs’ claims could rise or fall entirely based on the construction of state law,” the panel said.

The panel also rejected the defendants’ claim of federal jurisdiction under Section 27, which relied on a line of cases from the Ninth Circuit. Those cases are at odds with the Supreme Court’s 1961 decision in Pam American Petroleum Corp. v. Superior Court of Delaware, the panel said.

Plaintiff lawyer Flaster said he was pleased with the decision, since his clients would have been held to a higher standard on a defense motion to dismiss in federal court.

A Merrill Lynch spokesman, Bill Halldin, said the company had no comment about the ruling. Lawyers for the other defendants either did not return calls from a reporter or had no comment. Sophie Sohn, a spokeswoman for KCG, a successor by merger to Knight Capital, said her company had no comment.


http://www.law.com/sites/articles/2014/11/11/...tate-court

Nanotech Entertainment Inc. (NTEK) Stock Research Links

NTEK Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 354

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 86

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 146

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 627

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 26

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 129

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Wuliangye Aims for Global Branding Boost at Panda Event

Updated Category News Views 27

Wuliangye Takes Center Stage at Global Event Everyone's chasing that global branding magic, but here's Wuliangye strutting its stuff at the Global Panda Partners Conference. Held in Sichuan Province from November 2 to 4, this is not just another show; it's a bold move from the Chinese baijiu maker to push the 'harmony and coexistence' mantra on the world stage. Not just...

Continue Reading
ASMAX Unleashes Next-Level Motorcycle Comms at EICMA

Updated Category News Views 50

Transforming the Motorcycle Communication Landscape Motorcycling ain't just about the roaring engines and the rubber on the road. In the world of helmets and handlebars, some bright minds are weaving tech magic at the EICMA 2026 in Milan. ASMAX has rolled out its shiny new RoamX intercom gadget, leaving folks buzzing at Hall 6. What RoamX Brings to the Table This ain't...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 294

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading

Top 5 Most Recently Viewed Articles

Iceland Seafood International hf Announces Successful Bill Auction

Updated Category News Views 171

Iceland Seafood International hf's Successful Auction Iceland Seafood International hf. has recently completed an offering of 3-month bills under the new series ICESEA 25 0304. This significant milestone reflects the company's ongoing efforts to strengthen its financial position and enhance its market presence. Details of the Bill Auction The total offers for the bills...

Continue Reading
Prolong Pharmaceuticals Showcases PP-007 in Innovative Stroke Study

Updated Category News Views 194

Prolong Pharmaceuticals Highlights Phase 1 Results for Acute Ischemic Stroke Treatment Prolong Pharmaceuticals, LLC, a clinical-stage biopharmaceutical firm, is making waves in the medical community with its recent announcement regarding the preliminary data from the HEMERA-1 trial. This significant study looks into the effects of their lead asset, PP-007, in treating...

Continue Reading
Investors Urged to Join Class Action Against Verve Therapeutics

Updated Category News Views 89

Investors: Consider Joining the Verve Therapeutics Class Action Robbins LLP, a shareholder-rights law firm, is reminding investors about an important window to act in the class action against Verve Therapeutics, Inc. (NASDAQ: VERV). The lawsuit covers individuals and entities that bought or otherwise acquired Verve securities during a defined time frame. Verve is a...

Continue Reading
Top Dividend Stocks for Passive Income Success

Updated Category News Views 246

Building Passive Income Through Smart Investments Creating passive income is a crucial element of a successful early retirement plan. Establishing various sources of passive income is important to reduce the pressure of depending solely on active work for financial support. A key aspect of this strategy is investing in companies known for their above-average dividends,...

Continue Reading
Temperature Monitoring Devices Market Expected to Surge

Updated Category News Views 61

The temperature monitoring devices market experienced a notable surge back in 2024, with projections estimating a compound annual growth rate (CAGR) of 4.5% through to 2034. By the end of that forecast period, sales revenue was set to hit around USD 5.3 billion—a clear indicator of robust expansion in this critical sector. Market Dynamics: Diverse Applications Across...

Continue Reading